Endothelin-Converting Enzyme-Like 1 Regulated by LIF Contributes to Chronic Constriction Injury-Induced Neuropathic...

Area of Science:

• Neuroscience
• Pain Research
• Molecular Biology

Background:

• Neuropathic pain (NP) is a debilitating condition with limited treatment options.
• Endothelin-converting enzyme-like 1 (ECEL1) is implicated in various physiological processes, but its role in NP remains unclear.

Purpose of the Study:

• To investigate the role of ECEL1 in the development and maintenance of neuropathic pain.
• To explore the regulatory relationship between ECEL1 and leukemia inhibitory factor (LIF) in the context of NP.

Main Methods:

• Utilized a chronic constriction injury (CCI) mouse model to induce neuropathic pain.
• Modulated ECEL1 expression in dorsal root ganglion (DRG) neurons using adeno-associated virus 5 (AAV5) vectors.
• Administered intrathecal leukemia inhibitory factor (LIF) or LIF blockers to assess their effect on ECEL1 expression and pain.

Main Results:

• Downregulating ECEL1 in DRG neurons alleviated CCI-induced pain and neuronal hyperexcitability by inhibiting sympathetic sprouting.
• Overexpressing ECEL1 exacerbated pain hypersensitivity in the CCI model.
• LIF was found to upregulate ECEL1 expression, while LIF blockade reduced ECEL1 levels and mitigated nociception.

Conclusions:

• ECEL1 plays a critical role in promoting hyperalgesia following chronic constriction injury.
• ECEL1 expression is regulated by LIF, highlighting a novel signaling pathway in neuropathic pain.
• ECEL1 represents a promising therapeutic target for the treatment of neuropathic pain.